HLA-mismatched GPBSC infusion therapy in refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: an observational study from a single center

BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a severe or even fatal inflammatory state. Epstein–Barr virus (EBV) infection-associated HLH (EBV-HLH) is one of the most common secondary HLH and suffers a very poor prognosis. Allo-HSCT is often required for refractory EBV-HLH, but some patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Yue, Wang, Jingshi, Wang, Yini, Wang, Zhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329501/
https://www.ncbi.nlm.nih.gov/pubmed/32611452
http://dx.doi.org/10.1186/s13287-020-01779-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329501/
https://www.ncbi.nlm.nih.gov/pubmed/32611452
http://dx.doi.org/10.1186/s13287-020-01779-4

Ejemplares similares